Featured Content

Live Webinars

Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy

Live Virtual Webinar
SAVE THE DATE: Saturday, October 1, 2022 at 10 AM EDT


Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma
Live Virtual Webinar:
Wednesday, August 31, 2022 at 7 PM EDT

Rebroadcast:
Saturday, September 3, 2022 at 1 PM EDT
Tuesday, September 6, 2022 at 7 PM EDT
Thursday, September 8, 2022 at 7 PM EDT
Saturday, September 10, 2022 at 1 PM EDT


Improving Renal Cell Carcinoma Patient Outcomes with Multi-targeted TKIs and Immune Checkpoint Inhibitors
Live Virtual Webinar:
Thursday, August 18, 2022 at 7 PM EDT

Rebroadcasts:
Saturday, August 20, 2022 at 1 PM EDT
Tuesday, August 23, 2022 at 7 PM EDT
Thursday, August 25, 2022 at 7 PM EDT
Saturday, August 27, 2022 at 1 PM EDT

View All Live Programs

New Webcasts

Emerging Treatment Options for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Released on 6/24/22
Expires on 6/24/23


Emerging Treatment Options for Pustular Psoriasis
Released on 5/31/22
Expires on 5/31/23


Current and New Biomarkers and Targeted Therapy Options for Gastric and Gastroesophageal Junction Cancers
Released on 5/20/22
Expires on 5/20/23


Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis (ALS)
Released on 5/2/22
Expires on 5/2/23


Current and Emerging Treatment Options for Multiple Myeloma
Released on 4/7/22
Expires on 4/7/23


Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps
Released on 3/25/22
Expires on 3/25/23


Novel Treatment Options for Multiple Myeloma
Released on 3/24/22
Expires on 3/24/23


New and Emerging Treatment Options for Hematological Malignancies
Released on 12/30/21
Expires on 12/30/22


Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Released on 12/10/21
Expires on 12/10/22


Evolving Strategies in the Treatment of HER2-positive Metastatic Breast Cancer with Antibody-Drug Conjugates and Tyrosine Kinase Inhibitors
Released on 12/8/21
Expires on 12/8/22


Emerging Strategies in the Management of Genitourinary Cancers
Released on 11/22/21
Expires on 11/22/22


Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Released on 11/18/21
Expires on 11/18/22


Novel Therapies for Metastatic Castrate Resistant Prostate Cancer with PARP-Inhibitors and BITE Immunotherapy
Released on 11/8/21
Expires on 11/8/2


Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis
Released on 10/21/21
Expires on 10/21/22


Emerging Treatment Options for BRAF-mutant Colorectal Cancer
Released on 9/9/21
Expires on 9/9/22


Novel Treatment and Management Options for Chronic Idiopathic Constipation
Released on 7/23/21
Expires on 7/23/22


New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Released on 6/29/21
Expires on 6/29/22


New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Released on 6/14/21
Expires on 6/14/22


Changing Landscape of Treatment for Acute Lymphoblastic Leukemia
Released on 5/26/21
Expires on 5/26/22


New Paradigms in the Treatment and Management of Age-related Macular Degeneration (AMD)
Released on 4/30/21
Expires on 4/30/22


Biosimilars: Implications for Clinical Practice in Hematological Malignancies & Supportive Care
Released on 4/30/21
Expires on 4/30/22


Update on the Immune Checkpoint Inhibitor and Combination Targeted Therapies for Hepatocellular Carcinoma
Released on 3/18/20
Expires on 3/18/21


New Paradigms in the Biological Therapies for Atopic Dermatitis
Released on 3/10/20
Expires on 3/10/21


Changing Landscape of NSCLC with Targeted Therapies and Immunotherapy
Released on 12/08/20
Expires on 12/08/21


Advances in the Treatment of dMMR/MSI-H Colorectal Cancer with Immunotherapy
Released on 12/05/20
Expires on 12/05/21


Emerging Strategies in the Management of Chronic Fibrosing ILD Patients Who Have Contracted COVID-19
Released on 10/28/20
Expires on 10/28/21


Changing Landscape of Treatment Options for Multiple Myeloma
Released on 10/5/20
Expires on 10/5/21


Changing Landscape of Treatment Options for Hematological Malignancies
Released on 9/28/20
Expires on 9/28/21


Current and Emerging Treatment Options for Renal Cell Carcinoma
Released on 10/10/20
Expires on 10/18/21


Current and Emerging Treatment Options for Lung Cancer and Head & Neck Cancer
Released on 7/22/21
Expires on 7/30/21


Current and Emerging Treatment Options for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma)
Released on 6/15/20
Expires on 6/15/21


Changing Landscape of Treatment Options for Metastatic Urothelial Carcinoma
Released on 5/22/20
Expires on 5/22/21


New Paradigms in the Treatment of Relapsed Multiple Myeloma 
Released on 5/3/20
Expires on 5/3/21


New Paradigms in the Treatment Options for Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML): European Perspective
Released on 4/28/20
Expires on 4/28/21


Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma
Released on 12/30/19
Expires on 12/30/20

View All Webcasts